Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Pharmacorp Rx Inc. ( (TSE:PCRX) ) just unveiled an update.
PharmaCorp Rx Inc. has completed the acquisition of a pre-1954 charter company in Ontario, allowing it to own and operate pharmacies in the province, a significant strategic move due to regulatory restrictions. This acquisition marks a major milestone for PharmaCorp, enhancing its ability to expand its operations in Ontario and potentially strengthening its market position in the Canadian pharmaceutical industry.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. operates in the pharmaceutical industry, focusing on acquiring and operating pharmacies in Canada. The company currently manages three PharmaChoice bannered pharmacies and plans to expand by acquiring more PharmaChoice and independently owned pharmacies, rebranding them under the PharmaChoice Canada banner. PharmaCorp is listed on the TSX Venture Exchange under the symbol PCRX.
YTD Price Performance: 11.36%
Average Trading Volume: 21,045
Technical Sentiment Signal: Hold
Current Market Cap: C$51.46M
See more data about PCRX stock on TipRanks’ Stock Analysis page.